Structural and functional analysis of the interaction between the agonistic monoclonal antibody Apomab and the proapoptotic receptor DR5-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Structural and functional analysis of the interaction between the agonistic monoclonal antibody Apomab and the proapoptotic receptor DR5

Published:2008-01-25 Issue:4 Volume:15 Page:751-761
ISSN:1350-9047
Container-title:Cell Death & Differentiation
language:en
Short-container-title:Cell Death Differ

Author:

Adams C,Totpal K,Lawrence D,Marsters S,Pitti R,Yee S,Ross S,Deforge L,Koeppen H,Sagolla M,Compaan D,Lowman H,Hymowitz S,Ashkenazi A

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

http://www.nature.com/articles/4402306.pdf

Reference50 articles.

1. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P . Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18: 581–592.

2. Ross JS, Schenkein DP, Pietrusko R, Rolfe M, Linette GP, Stec J et al. Targeted therapies for cancer 2004. Am J Clin Pathol 2004; 22: 598–609.

3. Ashkenazi A . Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer 2002; 2: 420–430.

4. Fesik SW . Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer 2005; 5: 876–885.

5. Ghobrial IM, Witzig TE, Adjei AA . Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 2005; 55: 178–194.

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phage display for discovery of anticancer antibodies;New Biotechnology;2024-11

2. Chemical synthetic approaches to mimic the TRAIL: promising cancer therapeutics;RSC Medicinal Chemistry;2024

3. Characterizing the regulatory Fas (CD95) epitope critical for agonist antibody targeting and CAR-T bystander function in ovarian cancer;Cell Death & Differentiation;2023-10-14

4. Therapeutic targeting of TRAIL death receptors;Biochemical Society Transactions;2023-01-11

5. Autoinhibitory structure of preligand association state implicates a new strategy to attain effective DR5 receptor activation;Cell Research;2023-01-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3